Intellia Therapeutics (NTLA) Asset Utilization Ratio (2016 - 2025)
Intellia Therapeutics (NTLA) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.08 as the latest value for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio rose 56.41% to 0.08 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.08, a 56.41% increase, with the full-year FY2025 number at 0.07, up 43.31% from a year prior.
- Asset Utilization Ratio was 0.08 for Q4 2025 at Intellia Therapeutics, up from 0.06 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.08 in Q4 2025 to a low of 0.02 in Q3 2021.
- A 5-year average of 0.04 and a median of 0.04 in 2023 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: crashed 82.71% in 2021, then surged 136.33% in 2022.
- Intellia Therapeutics' Asset Utilization Ratio stood at 0.02 in 2021, then surged by 101.23% to 0.04 in 2022, then decreased by 28.75% to 0.03 in 2023, then soared by 71.69% to 0.05 in 2024, then surged by 56.41% to 0.08 in 2025.
- Per Business Quant, the three most recent readings for NTLA's Asset Utilization Ratio are 0.08 (Q4 2025), 0.06 (Q3 2025), and 0.06 (Q2 2025).